Ana Patricia Rodríguez-Zulueta

Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases

Dora Corzo-León, Luis David Chora-Hernández, Ana Patricia Rodríguez-Zulueta et al. · Medical Mycology · 2017 · 197 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Metabolic Reprogramming in SARS-CoV-2 Infection Impacts the Outcome of COVID-19 Patients

Laura E. Martínez-Gómez, Isabel Ibarra‐González, Cynthia Fernández‐Lainez et al. · Frontiers in Immunology · 2022 · 51 citations · Full text

Life Sciences, Biochemistry, Infectious Diseases +15

Comparison of Lateral Flow Immunochromatography and Phenotypic Assays to PCR for the Detection of Carbapenemase-Producing Gram-Negative Bacteria, a Multicenter Experience in Mexico

Braulio Josué Méndez-Sotelo, Luis Esaú López-Jácome, Claudia Adriana Colín‐Castro et al. · Antibiotics · 2023 · 19 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Outpatient ertapenem therapy in an ESBL-high-prevalence area: an efficacy, safety, and cost study

Arturo Ortiz-Álvarez, Mónica A Delgado-Ramírez, Montserrat Cuevas-Zuñiga et al. · Infection and Drug Resistance · 2018 · 11 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Antimicrobial Susceptibility Among Gram-Negative Isolates in Pediatric Patients in Latin America, Africa-Middle East, and Asia From 2016–2020 Compared to 2011–2015: Results From the ATLAS Surveillance Study

Qiwen Yang, Shweta Kamat, Naglaa Mohamed et al. · Journal of the Pediatric Infectious Diseases Society · 2023 · 10 citations · Full text

Life Sciences, Microbiology, Pediatrics +17